March 2012 Br J Cardiol 2012;19:24 doi:10.5837/bjc.2012.003
Rachael Boggon, Susan Eaton, Adam Timmis, Harry Hemingway, Zahava Gabriel, Iqbal Minhas, Tjeerd P van Staa
Introduction Cardiovascular disease (CVD) is the leading cause of death in England and Wales (124,000 deaths in 2005) and for every fatality, there are at least two people who have a major non-fatal CVD event.1 Myocardial infarction (MI) is associated with substantial morbidity and mortality. There is a high risk of recurrence after the initial event. Recommendations on the secondary prevention of cardiovascular disease for patients in primary and secondary care have been published in guidelines from the National Institute for Health and Clinical Excellence (NICE) in England.1,2 In the May 2008 CG67 guideline, high-intensity dosage of statin
July 2009 Br J Cardiol 2009;16:159–61
Christopher P Gale, Alex D Simms, Brian A Cattle, Phil D Batin, John S Birkhead, Darren S Greenwood, Alistair S Hall, Robert M West
Missing data Figure 1. Computed tomography (CT) sagittal reconstruction, two-chamber view. The subepicardial myocardium is thin and normally compacted with a thicker non-compacted subendocardial layer in the anterior wall and apex. Note the artefact from the right ventricular (RV) pacemaker tip There are, however, justified concerns with regard to MINAP data relating to data quality and completeness of ascertainment. These concerns reflect, in some cases, difficulties experienced by some hospitals with data collection. Systematic differences between patients with and without information recorded may bias the estimated performance of a hospita
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits